CD226 and graft versus host disease: This finding has potential implications for Treg ACT in settings of autoimmunity and transplantation: specifically, the preferential outgrowth of TCM from CD226- Tregs may lead to better engraftment efficiency and localization to secondary lymphoid organs where autoimmune priming and graft versus host disease (GvHD) are initiated (45).